TAOYUAN, Taiwan, March 25 (Reuters) - United Parcel Service opened a new $100 million logistics centre in ‌Taiwan on Wednesday, its largest in the Asia ‌Pacific, riding a wave of demand from tech companies. Taiwan is home ​to TSMC, the world's top contract chip-maker and dominant supplier of the advanced semiconductors powering the boom in AI technologies. UPS said the site in northern Taiwan's ‌Taoyuan, a short ⁠drive from the island's largest international airport, will also be used by Applied Materi ...

Ian Larkin Image of incoming CEO, Liberty Blume LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- Liberty Global’s (NASDAQ: LBTYA, LBTYB, and LBTYK) tech-enabled back-office solutions provider, Liberty Blume, has announced the appointment of Ian Larkin as Chief Executive Officer to lead the next phase of the company’s growth. Larkin brings more than 25 years of leadership experience across consultancy, financial services, technology, and global operations. He most recently served as CEO of TopSource Worldwide, ...

Core Insights - BingEx Limited, operating under the brand "FlashEx," reported its financial results for Q4 and the fiscal year 2025, highlighting a focus on service quality and AI technology integration to enhance operational efficiency and explore new logistics opportunities [1][3]. Financial Performance Highlights - Q4 2025 revenues were RMB1,001.3 million (US$143.2 million), a decrease from RMB1,028.9 million in Q4 2024, primarily due to reduced order volume amid heightened competition [4][5]. - For the fiscal year 2025, total revenues were RMB3,992.1 million (US$570.9 million), down from RMB4,468.2 million in 2024, also attributed to declining order volume [13]. - Gross profit for Q4 2025 was RMB107.9 million (US$15.4 million), with a gross profit margin of 10.8%, an improvement from 10.0% in Q4 2024 [4][6]. - The fiscal year 2025 gross profit was RMB469.1 million (US$67.1 million), with a gross profit margin of 11.8%, up from 11.0% in 2024 [13]. - The company achieved a net income of RMB22.5 million (US$3.2 million) in Q4 2025, compared to a net loss of RMB294.0 million in Q4 2024 [10][11]. - For the full year, net income was RMB109.4 million (US$15.6 million), a significant recovery from a net loss of RMB146.5 million in 2024 [17]. Operational Efficiency - Total operating expenses in Q4 2025 were RMB105.0 million (US$15.0 million), a decrease of 58.9% from RMB255.6 million in Q4 2024, largely due to the recognition of share-based compensation expenses in the previous year [7][8]. - Selling and marketing expenses decreased by 42.4% to RMB52.0 million (US$7.4 million) in Q4 2025 [7]. - Research and development expenses were reduced by 77.6% to RMB18.0 million (US$2.6 million) in Q4 2025 [8]. Share Repurchase Program - The Board of Directors approved a one-year extension of the existing share repurchase program, allowing for the repurchase of up to US$30 million worth of shares until April 1, 2027 [21]. - As of March 16, 2026, the company had repurchased approximately 2.8 million ADSs for a total consideration of about US$9.2 million [21]. Future Outlook - The company plans to continue enhancing user experience, supporting its rider community, and strengthening operational excellence while leveraging AI technologies for improved service management and exploring low-altitude delivery opportunities [3][5].

From @WSJFreeEx via @WSJOpinion: While new AI technologies will save many lives, it could also render many of us unable to complete daily tasks without assistance, writes @jamesbmeigshttps://t.co/ljlC12QW8E ...

From @WSJFreeEx via @WSJOpinion: While new AI technologies will save many lives, it could also render many of us unable to complete daily tasks without assistance, writes @jamesbmeigshttps://t.co/ntvA71Q9Gw ...

INTEGRITY | RESPECT | EXCELLENCE FOURTH QUARTER 2025 EARNINGS RELEASE JANUARY 28, 2026 FORWARD-LOOKING STATEMENTS & NON-GAAP FINANCIAL MEASURES The statements in this presentation that are not historical statements, including statements regarding the 2026 full-year outlook and expected consolidated and segment financial results, as well as financial targets for future years, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking state ...

Core Insights - InterDigital, Inc. has signed a significant patent license agreement with LG Electronics, covering LG's digital TVs and computer display monitors, utilizing technologies such as ATSC 3.0, Wi-Fi, and video codecs [1][5] - Roth Capital has reaffirmed a "Buy" rating for InterDigital following the agreement, leading to a positive outlook for 2026 [2] - InterDigital's stock price has increased to $329.51, reflecting a 6.72% rise, indicating strong investor interest [3][5] Company Overview - InterDigital focuses on research and development in mobile, video, and AI technologies, with a market capitalization of approximately $8.48 billion [4] - The company's innovations in advanced video compression, broadcast, and Wi-Fi are crucial for a wide range of devices and services [4] - The negotiation process with LG was amicable, highlighting the strategic importance of the agreement [4]

Group 1 - TransAlta Corporation (TAC) is a Canadian energy company that is positioned to benefit from the increasing demand for AI technologies, particularly as an energy provider for data centers [1] - The company operates in sectors that are critical for the growth of technology, energy, and consumer staples, indicating a diversified investment approach [1] Group 2 - The analyst emphasizes the potential in emerging markets, which adds a risk component to the investment portfolio [1]

Group 1 - The U.S. State Department approved an $11.15 billion arms sale to Taiwan, marking the largest arms sale of its kind amid increasing threats from China [1] - The arms package includes 82 HIMARS rocket artillery systems valued at $4.05 billion, 420 ATACMS missiles, unmanned surveillance systems, and military software [2] - Additional components of the sale consist of 60 M109A7 self-propelled howitzer systems valued at over $4 billion, along with Javelin and TOW anti-tank missiles worth more than $700 million [3] Group 2 - The arms sale is part of Taiwan's $40 billion supplemental defense budget announced by President Lai Ching-te [2] - The U.S. is not legally obligated to defend Taiwan but is committed to providing defense equipment under the 1979 Taiwan Relations Act [3] - The sale occurs amidst escalating tensions between the U.S., China, and Taiwan, with recent legislative actions from the U.S. government supporting Taiwan's defense [4]

Core Viewpoint - AlphaTON Capital Corp clarifies its investment program related to Anduril Industries, stating that it will not proceed with the tokenized investment program due to transfer restrictions on the underlying common stock [2][3]. Investment Program Clarification - AlphaTON has signed a contract to gain economic exposure to Anduril Industries' common stock through a Special Purpose Vehicle (SPV) structure, rather than a direct equity investment [2]. - The intention was to create a derivative tokenized product to meet the growing demand for exposure to innovative technology companies [2]. Cancellation of Anduril Program - The company has identified that the Anduril Industries common stock is subject to transfer restrictions, and Anduril will not consent to any transfer [3]. - Due to these limitations, AlphaTON has decided to cancel the Anduril tokenized investment program [3]. Commitment to Strategic Investments - AlphaTON remains committed to strategic investments and the tokenization of assets that provide clear ownership rights and align with shareholder value creation objectives [4]. Company Overview - AlphaTON Capital Corp is a leading technology public company focused on scaling the Telegram super app, targeting an addressable market of 1 billion monthly active users [5]. - The company employs a comprehensive M&A and treasury strategy, including direct token acquisition and strategic ecosystem investments to generate sustainable returns for shareholders [5]. - AlphaTON is also involved in drug development, focusing on therapies targeting checkpoint resistance pathways [6].